Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Cancer Institute (NCI)
This Notice is to inform the research community that the National Institutes of Health (NIH) Tobacco Regulatory Science Program (TRSP), participating NIH Institutes and Centers (ICs), and the United States Food and Drug Administration (FDA) Center for Tobacco Products (CTP) intend to reissue the Funding Opportunity Announcement (FOA) RFA-OD-19-022 "Secondary Analyses of Existing Dataset of Tobacco Use and Health (R21 Clinical Trial Not Allowed)." When reissued, this FOA will continue to utilize the R21 grant mechanism.
This Notice is being provided to allow potential eligible applicants sufficient time to develop competitive and responsive projects.
The FOA is expected to be published in Spring 2021. Details of the planned FOA are provided below.
The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications proposing the innovative analysis of existing (publicly available) nationally representative U.S. cross-sectional and longitudinal data, to investigate novel scientific ideas and/or to generate new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the Food and Drug Administration (FDA) - Center for Tobacco Products (CTP). Other publicly available data sets would be considered depending on the analyses to be conducted; however, nationally representative analyses will receive priority. Applications not using nationally representative data sets will need to provide justification why the data set is unique, and why the research questions cannot be answered from a (publicly available) nationally representative data set. This FOA encourages the analyses of public use datasets that may inform tobacco regulatory actions in the United States (U.S.).
NIH, via support from the FDA Center for Tobacco products (CTP), intends to fund up to 5 R21s, corresponding to a total of up to $1 million, for fiscal year 2021. Future year amounts will depend on availability of funds.
The combined budget for direct costs for the entire project period may not exceed $275,000. No more than $200,000 in direct cost may be requested in any single year.
Applications are not being solicited at this time.
Please direct all inquiries to:
Tobacco Regulatory Science Program
Office of Disease Prevention